Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations

Shranjeno v:

Bibliografske podrobnosti
izdano v:	Scientific Reports (Nature Publisher Group) vol. 15, no. 1 (2025), p. 28742-28754
Glavni avtor:	Khan, Mohd Shahnawaz
Drugi avtorji:	Shamsi, Anas, Shahwan, Moyad, Dinislam, Khuzin, Yadav, Dharmendra Kumar
Izdano:	Nature Publishing Group
Teme:	Food & Drug Administration > FDA Cancer PD-L1 protein Binders Bioinformatics Therapeutic targets Binding sites Biological products Drug development Computer applications Molecular dynamics Efficiency Proteins Simulation Principal components analysis FDA approval Immune checkpoint Antineoplastic drugs Pharmacokinetics Ligands Immunosuppressive agents Cancer therapies Environmental
Online dostop:	Citation/Abstract Full Text Full Text - PDF
Oznake:	Označite Brez oznak, prvi označite!

Komentirajte kot prvi!